Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
26.9M
-
Shares change
-
-884K
-
Total reported value, excl. options
-
$208M
-
Value change
-
-$5.61M
-
Put/Call ratio
-
5.9
-
Number of buys
-
24
-
Number of sells
-
-40
-
Price
-
$7.74
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q3 2016
88 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q3 2016.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.9M shares
of 159M outstanding shares and own 16.96% of the company stock.
Largest 10 shareholders include BRIDGER MANAGEMENT, LLC (5.2M shares), FMR LLC (4.86M shares), RA CAPITAL MANAGEMENT, LLC (4.63M shares), BAKER BROS. ADVISORS LP (2M shares), UBS ASSET MANAGEMENT AMERICAS INC (1.54M shares), VANGUARD GROUP INC (1.49M shares), BlackRock Fund Advisors (1.02M shares), BlackRock Institutional Trust Company, N.A. (954K shares), STATE STREET CORP (636K shares), and COLUMBUS CIRCLE INVESTORS (635K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.